Literature DB >> 19748226

Prevalence of acute repetitive seizures (ARS) in the United Kingdom.

Carlos Martinez1, Tim Sullivan, W Allen Hauser.   

Abstract

INTRODUCTION: "Acute repetitive seizures" (ARS) is a term to describe a condition manifest by multiple seizures occurring over a relatively brief period of time -generally 24 hours- in patients with epilepsy. There is limited information regarding the epidemiology of ARS in the general population.
METHODS: We performed a historical cohort study using data from the United Kingdom General Practice Research Database (GPRD) to identify all incident and prevalent cases of active epilepsy in 2005. From among this group, we identified individuals at risk for ARS. This included those with "catastrophic epilepsy syndromes of childhood" (CE), and those with a history of seizure clustering in the context of other epilepsy syndromes.
RESULTS: We identified 21,010 people with active epilepsy in the GPRD in 2005; prevalence 7.2/1000; age adjusted to the European Standard Population, 6.7; incidence 50/100,000 per year, age-adjusted 48/100,000. We identified 665 people at risk for ARS. The prevalence of CE in the general population was 1.2/10,000 and that of cluster seizures was 1.1/10,000. We estimated the crude prevalence of ARS in the general population to be 2.3/10,000; age adjusted 2.5 (CI, 2.3-2.7. The prevalence of ARS was highest in those 0-4 years of age (5.9/10,000) and fell with advancing age to 0.5/10,000 in those age 70 and older).
CONCLUSIONS: This is the first population-based study to provide information on the prevalence of ARS. ARS affects about 3% of the population with epilepsy and 0.02% of the general population. More studies are needed to further evaluate this serious epilepsy phenomenon.

Entities:  

Mesh:

Year:  2009        PMID: 19748226     DOI: 10.1016/j.eplepsyres.2009.08.006

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  13 in total

1.  Bursts of seizures in long-term recordings of human focal epilepsy.

Authors:  Philippa J Karoly; Ewan S Nurse; Dean R Freestone; Hoameng Ung; Mark J Cook; Ray Boston
Journal:  Epilepsia       Date:  2017-01-13       Impact factor: 5.864

Review 2.  Diabetes and epilepsy in children and adolescents.

Authors:  M Loredana Marcovecchio; Marianna Immacolata Petrosino; Francesco Chiarelli
Journal:  Curr Diab Rep       Date:  2015-04       Impact factor: 4.810

3.  Hope for new treatments for acute repetitive seizures.

Authors:  David Spencer
Journal:  Epilepsy Curr       Date:  2014-05       Impact factor: 7.500

Review 4.  Outpatient pharmacotherapy and modes of administration for acute repetitive and prolonged seizures.

Authors:  Heather Ravvin McKee; Bassel Abou-Khalil
Journal:  CNS Drugs       Date:  2015-01       Impact factor: 5.749

5.  The Plausibility of an Association Between Maternal Obesity and Onset of Childhood Epilepsy: A Well-Rounded, Robust Argument or a Thin Epidemiologic Association?

Authors:  Cynthia L Harden
Journal:  Epilepsy Curr       Date:  2017 Sep-Oct       Impact factor: 7.500

6.  Self-Esteem, Social Phobia and Depression Status in Patients with Epilepsy.

Authors:  Ayşe Kutlu; Gökçen Gökçe; Ülkü Büyükburgaz; Macit Selekler; Sezer KOMŞUOğLU
Journal:  Noro Psikiyatr Ars       Date:  2013-12-01       Impact factor: 1.339

7.  Risk of Seizures Associated with Antidepressant Use in Patients with Depressive Disorder: Follow-up Study with a Nested Case-Control Analysis Using the Clinical Practice Research Datalink.

Authors:  Marlene Bloechliger; Alessandro Ceschi; Stephan Rüegg; Hugo Kupferschmidt; Stephan Kraehenbuehl; Susan S Jick; Christoph R Meier; Michael Bodmer
Journal:  Drug Saf       Date:  2016-04       Impact factor: 5.606

8.  Lifestyle factors, psychiatric and neurologic comorbidities, and drug use associated with incident seizures among adult patients with depression: a population-based nested case-control study.

Authors:  Marlene Bloechliger; Alessandro Ceschi; Stephan Rüegg; Susan Sara Jick; Christoph Rudolf Meier; Michael Bodmer
Journal:  Eur J Epidemiol       Date:  2016-05-04       Impact factor: 8.082

9.  Antipsychotic drug use and the risk of seizures: follow-up study with a nested case-control analysis.

Authors:  Marlene Bloechliger; Stephan Rüegg; Susan S Jick; Christoph R Meier; Michael Bodmer
Journal:  CNS Drugs       Date:  2015-07       Impact factor: 5.749

10.  Seizure Clusters, Seizure Severity Markers, and SUDEP Risk.

Authors:  Manuela Ochoa-Urrea; Nuria Lacuey; Laura Vilella; Liang Zhu; Shirin Jamal-Omidi; M R Sandhya Rani; Johnson P Hampson; Mojtaba Dayyani; Jaison Hampson; Norma J Hupp; Shiqiang Tao; Rup K Sainju; Daniel Friedman; Maromi Nei; Catherine Scott; Luke Allen; Brian K Gehlbach; Victoria Reick-Mitrisin; Stephan Schuele; Jennifer Ogren; Ronald M Harper; Beate Diehl; Lisa M Bateman; Orrin Devinsky; George B Richerson; Guo-Qiang Zhang; Samden D Lhatoo
Journal:  Front Neurol       Date:  2021-02-12       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.